ScholarIQanswers from OpenAlex & ORCID
Stephen A. Harrison
ResearcherPublications, citations & collaboration network
Stephen A. Harrison is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Stephen A. Harrison have?
ScholarIQindexed works
Stephen A. Harrison has 748 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Stephen A. Harrison have?
ScholarIQcitation count
Stephen A. Harrison has 68,555 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Stephen A. Harrison?
ScholarIQh-index
Stephen A. Harrison has an h-index of 117 in OpenAlex.
What is the i10-index of Stephen A. Harrison?
ScholarIQi10-index
Stephen A. Harrison has an i10-index of 351 in OpenAlex.
What is the ORCID of Stephen A. Harrison?
ScholarIQorcid
The ORCID for Stephen A. Harrison is on the source record.
What is the OpenAlex record for Stephen A. Harrison?
ScholarIQopenalex
The OpenAlex for Stephen A. Harrison is on the source record.
What are the most-cited papers on Stephen A. Harrison?
ScholarIQmost cited works
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease
Mohammed Eslam, Arun J. Sanyal, Jacob George, Arun J. Sanyal, Brent A. Neuschwander‐Tetri, Claudio Tiribelli, David E. Kleiner, Elizabeth M. Brunt, Elisabetta Bugianesi, Hannele Yki‐Järvinen, Henning Grønbæk, Helena Cortez‐Pinto, Jacob George, Jian‐Gao Fan, Luca Valenti, Manal F. Abdelmalek, Manuel Romero‐Gómez, Mary E. Rinella, Marco Arrese, Mohammed Eslam, Pierre Bédossa, Philip N. Newsome, Quentin M. Anstee, Rajiv Jalan, Ramón Bataller, Rohit Loomba, Silvia Sookoian, Shiv Kumar Sarin, Stephen A. Harrison, Takumi Kawaguchi, Vincent Wai‐Sun Wong, Vlad Ratziu, Yusuf Yılmaz, Zobair M. Younossi
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
Mary E. Rinella, Jeffrey V. Lazarus, Vlad Ratziu, Sven Francque, Arun J. Sanyal, Fasiha Kanwal, Diana Romero, Manal F. Abdelmalek, Quentin M. Anstee, Juan Pablo Arab, Marco Arrese, Ramón Bataller, Ulrich Beuers, Jérôme Boursier, Elisabetta Bugianesi, Christopher D. Byrne, Graciela Castro‐Narro, Abhijit Chowdhury, Helena Cortez‐Pinto, Donna R. Cryer, Kenneth Cusi, Mohamed El‐Kassas, Samuel Klein, Wayne Eskridge, Jian‐Gao Fan, Samer Gawrieh, Cynthia D. Guy, Stephen A. Harrison, Seung Up Kim, Bart G.P. Koot, Marko Korenjak, Kris V. Kowdley, Florence Lacaille, Rohit Loomba, Robert Mitchell-Thain, Timothy R. Morgan, Elisabeth E. Powell, Michael Roden, Manuel Romero‐Gómez, Marcelo Silva, Shivaram Prasad Singh, Silvia Sookoian, C Wendy Spearman, Dina Tiniakos, Luca Valenti, Miriam B. Vos, Vincent Wai‐Sun Wong, Stavra A. Xanthakos, Yusuf Yılmaz, Zobair M. Younossi, Ansley Hobbs, Marcela Villota‐Rivas, Philip N. Newsome, on behalf of the NAFLD Nomenclature consensus group
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
Mary E. Rinella, Jeffrey V. Lazarus, Vlad Ratziu, Sven Francque, Arun J. Sanyal, Fasiha Kanwal, Diana Romero, Manal F. Abdelmalek, Quentin M. Anstee, Juan Pablo Arab, Marco Arrese, Ramón Bataller, Ulrich Beuers, Jérôme Boursier, Elisabetta Bugianesi, Christopher D. Byrne, Graciela Castro‐Narro, Abhijit Chowdhury, Helena Cortez‐Pinto, Donna R. Cryer, Kenneth Cusi, Mohamed El‐Kassas, Samuel Klein, Wayne Eskridge, Jian‐Gao Fan, Samer Gawrieh, Cynthia D. Guy, Stephen A. Harrison, Seung Up Kim, Bart G.P. Koot, Marko Korenjak, Kris V. Kowdley, Florence Lacaille, Rohit Loomba, Robert Mitchell-Thain, Timothy R. Morgan, Elisabeth E. Powell, Michael Roden, Manuel Romero‐Gómez, Marcelo Silva, Shivaram Prasad Singh, Silvia Sookoian, C Wendy Spearman, Dina Tiniakos, Luca Valenti, Miriam B. Vos, Vincent Wai‐Sun Wong, Stavra A. Xanthakos, Yusuf Yılmaz, Zobair M. Younossi, Ansley Hobbs, Marcela Villota‐Rivas, Philip N. Newsome
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
Philip N. Newsome, Kristine Buchholtz, Kenneth Cusi, Martin Linder, Takeshi Okanoue, Vlad Ratziu, Arun J. Sanyal, Anne‐Sophie Sejling, Stephen A. Harrison
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Zobair M. Younossi, Vlad Ratziu, Rohit Loomba, Mary E. Rinella, Quentin M. Anstee, Zachary Goodman, Pierre Bédossa, Andreas Geier, Susanne Beckebaum, Philip N. Newsome, David Sheridan, Muhammad Y. Sheikh, James F. Trotter, W Knapple, Eric Lawitz, Manal F. Abdelmalek, Kris V. Kowdley, Aldo J. Montaño‐Loza, Jérôme Boursier, Philippe Mathurin, Elisabetta Bugianesi, G. Mazzella, Antonio Olveira, Helena Cortez‐Pinto, Isabel Graupera, David Orr, Lise Lotte Gluud, Jean‐François Dufour, David E. Shapiro, Jason Campagna, Luna Zaru, Leigh MacConell, Reshma Shringarpure, Stephen A. Harrison, Arun J. Sanyal, Manal F. Abdelmalek, Gary A. Abrams, Humberto Aguilar, Aijaz Ahmed, Elmar Aigner, Guruprasad P. Aithal, Aftab Ala, William Alazawi, Agustı́n Albillos, Michael Allison, Sfa Al-Shamma, Raúl J. Andrade, Pietro Andreoné, M. Angélico, Victor Ankoma‐Sey, Quentin M. Anstee, Rodolphe Anty, Víctor Araya, Juan Ignacio Arenas Ruiz, Perttu Arkkila, Marty Arora, Tarik Asselah, Jennifer Au, Oyekoya T. Ayonrinde, Robert J. Bailey, Maya Balakrishnan, Kiran Bambha, Meena B. Bansal, Sidney Barritt, John Bate, Jorge Beato, Susanne Beckebaum, Jaideep Behari, Pablo Bellot, Ziv Ben Ari, Michael Bennett, Marina Berenguer, Benedetta Terziroli Beretta‐Piccoli, Thomas Berg, Maurizio Bonacini, Lucía Bonet, Brian B. Borg, Marc Bourlière, Jérôme Boursier, William D. Bowman, David Bradley, Marija Branković, Marius Braun, Jean-Pierre Bronowicki, Savino Bruno, Elisabetta Bugianesi, Cindy X. Cai, Amy Calderon, José Luis Calleja Panero, Elizabeth J. Carey, Michal Carmiel, J.A. Carrión, Matthew C. Cave, Cristina Chagas, Tawfik N. Chami, Alan K. Chang, Allan Coates, Jeremy Cobbold, Charlote Costentin, Kathleen E. Corey